![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 30, 2016 4:40:51 PM
"Norchi has deep contacts in the world of contract manufacturing. Norchi said that Arch had spoken with many candidate contract manufacturers, and wanted one that could do scaled-up liquid phase peptide synthesis on both sides of the Atlantic equally. A contract is in place, and this organization is now making AC5 stocks. Norchi felt it would imprudent to name right now the manufacturer or the cost per unit for manufacture, but assured us that despite the relative expensiveness of making AC5, he is confident a price with considerable profit margin that the market will easily bear without drama or protest can be set. Arch has a consulting advisor who is the author of the leading textbook in biochemistry on methods of peptide synthesis."
Arch Therapeutics Science
http://sciencebehindac5.blogspot.com/
Elevator Summary of Arch http://www.archtherapeutics.blogspot.com/
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM